These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 31130303)

  • 1. And now we have the AUGUSTUS … How will it impact on antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention?
    Rubboli A
    Eur J Intern Med; 2019 Jul; 65():1-3. PubMed ID: 31130303
    [No Abstract]   [Full Text] [Related]  

  • 2. Navigating the treacherous waters of antithrombotic therapies in patients with atrial fibrillation and coronary artery disease: Lessons from AUGUSTUS.
    Harskamp RE; Alexander JH; Lopes RD
    Eur J Intern Med; 2019 Jul; 65():4-5. PubMed ID: 31128977
    [No Abstract]   [Full Text] [Related]  

  • 3. Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial.
    Windecker S; Lopes RD; Massaro T; Jones-Burton C; Granger CB; Aronson R; Heizer G; Goodman SG; Darius H; Jones WS; Aschermann M; Brieger D; Cura F; Engstrøm T; Fridrich V; Halvorsen S; Huber K; Kang HJ; Leiva-Pons JL; Lewis BS; Malaga G; Meneveau N; Merkely B; Milicic D; Morais J; Potpara TS; Raev D; Sabaté M; de Waha-Thiele S; Welsh RC; Xavier D; Mehran R; Alexander JH;
    Circulation; 2019 Dec; 140(23):1921-1932. PubMed ID: 31557056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of antithrombotic therapy with new oral anticoagulants in patients with atrial fibrillation after percutaneous coronary intervention.
    Siddiqi R; Yamani N; Alnaimat S; Khurshid A; Siddiqui S; Khan MS; Khan SU
    Eur J Prev Cardiol; 2020 Dec; 27(19):2119-2122. PubMed ID: 31349774
    [No Abstract]   [Full Text] [Related]  

  • 5. Stent Thrombosis With Dual Antithrombotic Therapy in Atrial Fibrillation-ACS/PCI Trials.
    Galli M; Andreotti F; D'Amario D; Porto I; Crea F
    J Am Coll Cardiol; 2020 Apr; 75(14):1727-1728. PubMed ID: 32273039
    [No Abstract]   [Full Text] [Related]  

  • 6. Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2018 Update.
    Angiolillo DJ; Goodman SG; Bhatt DL; Eikelboom JW; Price MJ; Moliterno DJ; Cannon CP; Tanguay JF; Granger CB; Mauri L; Holmes DR; Gibson CM; Faxon DP
    Circulation; 2018 Jul; 138(5):527-536. PubMed ID: 30571525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: should we change our practice after the PIONEER AF-PCI and RE-DUAL PCI trials?
    Duerschmied D; Brachmann J; Darius H; Frey N; Katus HA; Rottbauer W; Schäfer A; Thiele H; Bode C; Zeymer U
    Clin Res Cardiol; 2018 Jul; 107(7):533-538. PubMed ID: 29679144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2016 Update.
    Angiolillo DJ; Goodman SG; Bhatt DL; Eikelboom JW; Price MJ; Moliterno DJ; Cannon CP; Tanguay JF; Granger CB; Mauri L; Holmes DR; Gibson CM; Faxon DP
    Circ Cardiovasc Interv; 2016 Nov; 9(11):. PubMed ID: 27803042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombotic therapy in patients with atrial fibrillation undergoing PCI remains a moving target, yet with a clearer direction!
    Vranckx P; Valgimigli M
    EuroIntervention; 2022 Jul; 18(4):e267-e268. PubMed ID: 35866255
    [No Abstract]   [Full Text] [Related]  

  • 10. Triple antithrombotic therapy for atrial fibrillation and coronary stents.
    Shmyr D; Van der Merwe V; Yakiwchuk E; Barry A; Kosar L
    Can Fam Physician; 2017 May; 63(5):375-381. PubMed ID: 28500198
    [No Abstract]   [Full Text] [Related]  

  • 11. Algorithm for the management of antithrombotic therapy in atrial fibrillation patients undergoing percutaneous coronary intervention: an updated proposal based on efficacy considerations.
    Rubboli A; Lip GYH
    Eur Heart J Cardiovasc Pharmacother; 2020 Jul; 6(3):197-198. PubMed ID: 31942967
    [No Abstract]   [Full Text] [Related]  

  • 12. [Recent advances in antithrombotic therapy for patients with coronary artery disease undergoing percutaneous coronary intervention].
    Liu HW; Han YL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Feb; 49(2):108-110. PubMed ID: 33611894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triple, dual, and single antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Saito Y; Kobayashi Y
    Cardiovasc Interv Ther; 2020 Jan; 35(1):44-51. PubMed ID: 31281936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hospitalization Among Patients With Atrial Fibrillation and a Recent Acute Coronary Syndrome or Percutaneous Coronary Intervention Treated With Apixaban or Aspirin: Insights From the AUGUSTUS Trial.
    Vora AN; Alexander JH; Wojdyla DM; Aronson R; Granger CB; Darius H; Windecker S; Mehran R; Averkov O; Budaj A; Kong DF; Kobalava Z; Mehta RH; Mirza Z; Guimaraes PO; Parkhomenko A; Quadros A; Thiele H; Goodman SG; Lopes RD
    Circulation; 2019 Dec; 140(23):1960-1963. PubMed ID: 31553201
    [No Abstract]   [Full Text] [Related]  

  • 15. Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease.
    Lopes RD; Rao M; Simon DN; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Go AS; Hylek EM; Kowey P; Piccini JP; Singer DE; Chang P; Peterson ED; Mahaffey KW
    Am J Med; 2016 Jun; 129(6):592-599.e1. PubMed ID: 26797080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.
    Kuno T; Ueyama H; Takagi H; Ando T; Numasawa Y; Briasoulis A; Fox J; Bangalore S
    Am J Cardiol; 2020 Feb; 125(4):521-527. PubMed ID: 31839147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence, Management, and Long-Term (6-Year) Outcomes of Atrial Fibrillation Among Patients Receiving Drug-Eluting Coronary Stents.
    Choi HI; Ahn JM; Kang SH; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
    JACC Cardiovasc Interv; 2017 Jun; 10(11):1075-1085. PubMed ID: 28527773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triple Antithrombotic Therapy vs. Double Antithrombotic Therapy: One Scenario, 8 Questions, Many Conclusions.
    Aloia E; Orselli P; Sciaccaluga C
    Curr Cardiol Rev; 2019; 15(3):219-223. PubMed ID: 30636613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Antithrombotic Therapy: Beyond Coronary Artery Disease.
    Mystakidi VC; Oikonomou E; Tousoulis D
    Curr Pharm Des; 2020; 26(23):2683-2685. PubMed ID: 32586236
    [No Abstract]   [Full Text] [Related]  

  • 20. 2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA).
    Lip GYH; Collet JP; Haude M; Byrne R; Chung EH; Fauchier L; Halvorsen S; Lau D; Lopez-Cabanillas N; Lettino M; Marin F; Obel I; Rubboli A; Storey RF; Valgimigli M; Huber K;
    Europace; 2019 Feb; 21(2):192-193. PubMed ID: 30052888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.